Ginkgo Bioworks Holdings, Inc.DNANYSE
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank83
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-149.63%
↑ 49% vs avg
Percentile
P83
Within normal range
Streak
4 yr
Consecutive growthExpanding
Average
-290.70%
Historical baseline
PeriodValueYoY Change
2025-149.63%+29.9%
2024-213.35%+34.7%
2023-326.62%+24.2%
2022-431.16%+25.1%
2021-575.67%-306.4%
2020-141.65%+28.0%
2019-196.85%-